Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Natoli

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Anticancer Research|May 1, 1994
Elevated serum levels of a 90,000 daltons tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV)C Natoli, L Ortona, E Tamburrini, et al.
The Journal of Biological Chemistry|July 15, 1994
The secreted tumor-associated antigen 90K is a potent immune stimulatorA Ullrich, I Sures, M D'Egidio, et al.
Anticancer Research|February 24, 2001
Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90KA G Zeimet, S Stadlmann, C Natoli, et al.
Journal of Hepatology|August 1, 1996
Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patientsM Artini, C Natoli, N Tinari, et al.
International Journal of Cancer|April 21, 1995
Expression of tumor-associated 90K-antigen in human breast cancer: no correlation with prognosis and response to first-line therapy with tamoxifenJ A Foekens, J G Klijn, C Natoli, et al.
Anticancer Research|July 25, 1998
A phase II study of neoadjuvant chemotherapy with cisplatin epirubicin and VP-16 for stage III unresectable non-small cell lung cancerS Iacobelli, L Irtelli, R Sacco, et al.
Molecular Biology and Evolution|May 19, 2016
Evolution of Vertebrate Phototransduction: Cascade ActivationTrevor D Lamb, Hardip Patel, Aaron Chuah, et al.
Apoptosis : an International Journal on Programmed Cell Death|November 25, 2003
Cyclooxygenase-independent induction of p21WAF-1/cip1, apoptosis and differentiation by L-745,337, a selective PGH synthase-2 inhibitor, and salicylate in HT-29 cellsG Santini, M G Sciulli, R Marinacci, et al.
Biochimica Et Biophysica Acta|March 5, 2011
Unknown primary tumorsC Natoli, V Ramazzotti, O Nappi, et al.
Clinical and Experimental Immunology|September 16, 1998
Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein familyB Silvestri, F Calderazzo, V Coppola, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Anticancer Research|May 1, 1994
Elevated serum levels of a 90,000 daltons tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV)C Natoli, L Ortona, E Tamburrini, et al.
The Journal of Biological Chemistry|July 15, 1994
The secreted tumor-associated antigen 90K is a potent immune stimulatorA Ullrich, I Sures, M D'Egidio, et al.
Anticancer Research|February 24, 2001
Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90KA G Zeimet, S Stadlmann, C Natoli, et al.
Journal of Hepatology|August 1, 1996
Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patientsM Artini, C Natoli, N Tinari, et al.
International Journal of Cancer|April 21, 1995
Expression of tumor-associated 90K-antigen in human breast cancer: no correlation with prognosis and response to first-line therapy with tamoxifenJ A Foekens, J G Klijn, C Natoli, et al.
Anticancer Research|July 25, 1998
A phase II study of neoadjuvant chemotherapy with cisplatin epirubicin and VP-16 for stage III unresectable non-small cell lung cancerS Iacobelli, L Irtelli, R Sacco, et al.
Molecular Biology and Evolution|May 19, 2016
Evolution of Vertebrate Phototransduction: Cascade ActivationTrevor D Lamb, Hardip Patel, Aaron Chuah, et al.
Apoptosis : an International Journal on Programmed Cell Death|November 25, 2003
Cyclooxygenase-independent induction of p21WAF-1/cip1, apoptosis and differentiation by L-745,337, a selective PGH synthase-2 inhibitor, and salicylate in HT-29 cellsG Santini, M G Sciulli, R Marinacci, et al.
Biochimica Et Biophysica Acta|March 5, 2011
Unknown primary tumorsC Natoli, V Ramazzotti, O Nappi, et al.
Clinical and Experimental Immunology|September 16, 1998
Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein familyB Silvestri, F Calderazzo, V Coppola, et al.
Pageof 10